Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Anaplastic lymphoma kinase (AL...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Export Ready — 
Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: A rare entity

Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: A rare entity

Bibliographic Details
Main Authors: Ritesh Sachdev, Shalini Goel, Sunil Gupta, Nitin Sood
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Indian Journal of Pathology and Microbiology
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=1;spage=157;epage=158;aulast=Sachdev
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=1;spage=157;epage=158;aulast=Sachdev

Similar Items

  • ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement
    by: Smeeta Gajendra, et al.
    Published: (2015-01-01)
  • An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
    by: Suzanne D. Turner
    Published: (2017-10-01)
  • Anaplastic lymphoma kinase positive variant of anaplastic large cell lymphoma: A rare entity
    by: Venkata Satya Ramesh Thummala, et al.
    Published: (2014-01-01)
  • From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
    by: Michael T. Werner, et al.
    Published: (2017-10-01)
  • Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.
    by: Leandro Cerchietti, et al.
    Published: (2011-01-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...